Clinical skin cancer · 2016 · 14 citations · 15 references
MedicineMedicinal ChemistryOncologyCancer PharmacologyMetastasisMolecular OncologyMalignant NeoplasmsMelanocytic TumorsMelanoma PharmacotherapyTargeted Cancer TherapyBraf V600 MutationsBraf V600e MutationCancer Cell Proliferation InhibitionMelanocytic Tumor ProgressionMelanoma ProgressionMetastatic Melanoma Treatment
15
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn, Carla Milagre, Steven R. Whittaker et al. · Cell · 2010 · 1.5K citations · Full text
Principles of activation and permeation in an anion-selective Cys-loop receptor
Ryan Hibbs, Eric Gouaux · Nature · 2011 · 997 citations
Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
Clara Montagut, Sreenath V. Sharma, Toshi Shioda et al. · Cancer Research · 2008 · 504 citations · Full text
Medicine, Cancer Biology, Oncology +17